16-84405153-A-T

Variant summary

Our verdict is Likely benign. The variant received -5 ACMG points: 0P and 5B. BP6BS2

The NM_014861.4(ATP2C2):​c.236A>T​(p.Glu79Val) variant causes a missense change. The variant allele was found at a frequency of 0.00104 in 1,613,816 control chromosomes in the GnomAD database, including 4 homozygotes. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.00066 ( 0 hom., cov: 32)
Exomes 𝑓: 0.0011 ( 4 hom. )

Consequence

ATP2C2
NM_014861.4 missense

Scores

1
8
10

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:1

Conservation

PhyloP100: 6.72

Publications

5 publications found
Variant links:
Genes affected
ATP2C2 (HGNC:29103): (ATPase secretory pathway Ca2+ transporting 2) Enables P-type calcium transporter activity and P-type manganese transporter activity. Predicted to be involved in calcium ion transmembrane transport; cellular calcium ion homeostasis; and manganese ion transport. Predicted to act upstream of or within mammary gland epithelium development; positive regulation of calcium ion import; and protein localization to plasma membrane. Predicted to be located in trans-Golgi network membrane. Predicted to be active in Golgi membrane; endoplasmic reticulum; and plasma membrane. Predicted to be integral component of membrane. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -5 ACMG points.

BP6
Variant 16-84405153-A-T is Benign according to our data. Variant chr16-84405153-A-T is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 2048303.We mark this variant Likely_benign, oryginal submissions are: {Uncertain_significance=1, Likely_benign=1}.
BS2
High Homozygotes in GnomAdExome4 at 4 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ATP2C2NM_014861.4 linkc.236A>T p.Glu79Val missense_variant Exon 3 of 27 ENST00000262429.9 NP_055676.3 O75185-1
ATP2C2NM_001286527.3 linkc.236A>T p.Glu79Val missense_variant Exon 3 of 28 NP_001273456.2 O75185-3
ATP2C2XM_011523486.3 linkc.167A>T p.Glu56Val missense_variant Exon 3 of 28 XP_011521788.1
ATP2C2XM_047434994.1 linkc.167A>T p.Glu56Val missense_variant Exon 3 of 27 XP_047290950.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ATP2C2ENST00000262429.9 linkc.236A>T p.Glu79Val missense_variant Exon 3 of 27 1 NM_014861.4 ENSP00000262429.4 O75185-1
ATP2C2ENST00000416219.7 linkc.236A>T p.Glu79Val missense_variant Exon 3 of 28 1 ENSP00000397925.2 O75185-3
ATP2C2ENST00000565631.5 linkn.727A>T non_coding_transcript_exon_variant Exon 1 of 25 2
ATP2C2ENST00000569207.5 linkn.-68A>T upstream_gene_variant 5 ENSP00000456595.1 H3BS90

Frequencies

GnomAD3 genomes
AF:
0.000665
AC:
101
AN:
151886
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000290
Gnomad AMI
AF:
0.00110
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.000473
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00121
Gnomad OTH
AF:
0.000478
GnomAD2 exomes
AF:
0.000489
AC:
122
AN:
249524
AF XY:
0.000517
show subpopulations
Gnomad AFR exome
AF:
0.000323
Gnomad AMR exome
AF:
0.0000579
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.000279
Gnomad NFE exome
AF:
0.000945
Gnomad OTH exome
AF:
0.000330
GnomAD4 exome
AF:
0.00107
AC:
1570
AN:
1461812
Hom.:
4
Cov.:
31
AF XY:
0.00105
AC XY:
766
AN XY:
727204
show subpopulations
African (AFR)
AF:
0.000329
AC:
11
AN:
33480
American (AMR)
AF:
0.0000447
AC:
2
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.0000383
AC:
1
AN:
26136
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39698
South Asian (SAS)
AF:
0.0000116
AC:
1
AN:
86256
European-Finnish (FIN)
AF:
0.000244
AC:
13
AN:
53370
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5768
European-Non Finnish (NFE)
AF:
0.00134
AC:
1493
AN:
1111986
Other (OTH)
AF:
0.000811
AC:
49
AN:
60394
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.471
Heterozygous variant carriers
0
77
154
232
309
386
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
60
120
180
240
300
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000664
AC:
101
AN:
152004
Hom.:
0
Cov.:
32
AF XY:
0.000606
AC XY:
45
AN XY:
74298
show subpopulations
African (AFR)
AF:
0.000290
AC:
12
AN:
41446
American (AMR)
AF:
0.00
AC:
0
AN:
15262
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3468
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5158
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4802
European-Finnish (FIN)
AF:
0.000473
AC:
5
AN:
10576
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00121
AC:
82
AN:
67976
Other (OTH)
AF:
0.000473
AC:
1
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.510
Heterozygous variant carriers
0
4
9
13
18
22
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000898
Hom.:
0
Bravo
AF:
0.000559
TwinsUK
AF:
0.00162
AC:
6
ALSPAC
AF:
0.00156
AC:
6
ESP6500AA
AF:
0.000237
AC:
1
ESP6500EA
AF:
0.000472
AC:
4
ExAC
AF:
0.000454
AC:
55
Asia WGS
AF:
0.000289
AC:
1
AN:
3476
EpiCase
AF:
0.00153
EpiControl
AF:
0.000830

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:1
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not specified Uncertain:1
Aug 13, 2021
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.236A>T (p.E79V) alteration is located in exon 3 (coding exon 3) of the ATP2C2 gene. This alteration results from a A to T substitution at nucleotide position 236, causing the glutamic acid (E) at amino acid position 79 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

not provided Benign:1
Jan 18, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.14
BayesDel_addAF
Benign
-0.22
T
BayesDel_noAF
Benign
-0.12
CADD
Benign
23
DANN
Uncertain
0.99
DEOGEN2
Benign
0.023
T;.
Eigen
Uncertain
0.41
Eigen_PC
Uncertain
0.44
FATHMM_MKL
Pathogenic
0.98
D
LIST_S2
Benign
0.84
T;T
M_CAP
Benign
0.049
D
MetaRNN
Uncertain
0.62
D;D
MetaSVM
Uncertain
-0.22
T
MutationAssessor
Uncertain
2.5
M;M
PhyloP100
6.7
PrimateAI
Benign
0.46
T
PROVEAN
Uncertain
-2.9
D;D
REVEL
Uncertain
0.55
Sift
Benign
0.22
T;T
Sift4G
Benign
0.25
T;T
Polyphen
0.89
P;.
Vest4
0.71
MVP
0.72
ClinPred
0.059
T
GERP RS
5.1
Varity_R
0.16
gMVP
0.52
Mutation Taster
=57/43
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs201569578; hg19: chr16-84438759; COSMIC: COSV52294205; COSMIC: COSV52294205; API